期刊文献+

CgA和SYN在非小细胞肺癌中的表达及与预后的关系 被引量:2

Expression and prognostic significance of CgA and SYN in patients with non-small cell lung cancer
下载PDF
导出
摘要 目的研究神经内分泌分化(ND)标志物嗜铬蛋白A(CgA)和突触素(SYN)在可切除的非小细胞肺癌(NSCLC)组织中的表达及其与预后的关系。方法2000年1月~2003年1月收治NSCLC且接受手术治疗的患者共123例。收集手术切除标本以及患者临床和术后随访资料等。应用免疫组化二步法检测肿瘤组织标本中CgA和SYN的表达;分别采用Kaplan.Meier生存曲线和Cox风险比例模型进行单因素和多因素生存分析。结果切除的肿瘤组织标本中CgA和SYN的阳性表达率分别为22%和17.9%;SYN阳性表达与肿瘤分化程度相关(P=0.001);NSCLC伴ND(NSCLC—ND)(CgA和SYN任意一项表达阳性)与患者性别、年龄、吸烟指数、TNM分期和病理类型无明显相关。耐受化疗次数在CgA、SYN呈阳性表达与阴性表达的NSCLC患者之间无明显差异(P=0.406)。Kaplan—Meier生存分析显示,CgA和SYN表达与患者生存期相关;Cox多因素分析表明,肿瘤组织中SYN阳性表达(P=0.001)、TNM分期(P=0.02)和最大直径(P=0.049)是影响患者预后的独立危险因素。结论NSCLC—ND患者预后较差,其标记物SYN可作为临床判断预后的指标之一。 Objective To study the expression and prognostic significance of neuroendocrine differentiation markers chromogranin A (CgA)and synaptophysin (SYN) in patients with resectable non-small cell lung cancer (NSCLC). Methods From January 2000 to January 2003, 123 patients with NSCLC who received operations were investigated. The resected specimens and clinical data were collected. Immunohistochemical Elivison method was used to detecte the expression of CgA and SYN. Kaplan-Meier survival curve and Cox proportional hazard model multivariate analysis were applied for the prognostic factors. Results The positive expression rates of CgA and SYN were 22%, 17. 9%, respectively. The expression of SYN was associated with histological differentiation (P =0. 001). No significant association was found between NSCLC with neuroendocrine differentiation (NSCLC-ND) and sex, age, smoke index, TNM Stage and pathology classification. No evidence showed the patients wit~ positive expression of CgA or SYN could be tolerant with more cycles of chemotherapy (P = 0. 406). Kaplan-Meier survival curve indicated the survival had a relation with the expression of CgA and SYN. It was revealed by Cox analysis that SYN (P =0. 001 ) ,TNM stage (P =0.02)and the maximal diameter of tumor (P = 0. 049 ) were independent prognostic factors. Conclusion The patients with NSCLC-ND had a poorer prognosis. SYN may be one of the prognostic factors in patients with NSCLC.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2008年第9期1100-1103,1114,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 非小细胞肺癌 嗜铬蛋白A 突触素 神经内分泌分化 预后 non-small cell lung cancer chromogranin A synaptophysin neuroendocrine differentiation prognosis
  • 相关文献

参考文献13

  • 1Gazdar AF, Helman LJ, Israel MA, et al. Expression of neuroendo- crine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin[J]. Cancer Res, 1988,48(14) :4078 -4082. 被引量:1
  • 2范理宏,蔡映云.神经内分泌分化与非小细胞肺癌[J].肿瘤,2006,26(6):579-581. 被引量:6
  • 3Kasprzak A, Zabel M, Biczysko W. Selected markers (chromogranin A, neuron-specific enolase, synaptophysin, protein gene product 9. 5 ) in diagnosis and prognosis of neuroendocrine pulmonary tumours[ J ]. Pol J Pathol, 2007,58 (1):23 -33. 被引量:1
  • 4Slodkowska J,Zych J,Szturmowicz M, et al. Neuroendocrine phenotype of non-small cell lung carcinoma : immunohistological evaluation and biochemical study [ J ]. Int J Biol Markers, 2005,20 ( 4 ) : 217 - 226. 被引量:1
  • 5徐美林,刘岩,宋秀娴,杨霞.非小细胞肺癌伴神经内分泌分化的免疫组织化学研究[J].中国肿瘤临床,2005,32(3):165-167. 被引量:6
  • 6Sundaresan V, Reeve JG, Stenning S, et al. Neuroendocrine differentiation and clinical behaviour in non-small cell lung tumours[J]. Br J Cancer, 1991,66(2) :333 -338. 被引量:1
  • 7Pelosi G, Pasini F, Sonzogni A, et al. Prognostic implications of neuroendocrine differentiation and hormone production in patients with stage Ⅰ non-small cell lung carcinoma [J]. Cancer, 2003, 97 (10) :2487 -2497. 被引量:1
  • 8Howe MC, Chapman A, Kerr K,et,al. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy[J]. Histopathology, 2005,46 (2) : 195 - 201. 被引量:1
  • 9Nisman B, Heching N, Biran H. The prognostic significance of circulating neuroendocrine markers chromogranin a, pro-gastrin-releasing peptide and neuron-specific enolase in patients with advanced non-small-cell lung cancer[J]. Tumour Biol, 2006, 27 ( 1 ) : 8 -16. 被引量:1
  • 10Garcia-Yuste M, Matilla JM, Gonzalez-Aragoneses F. Neuroendocrine tumors of the lung[ J ]. Curt Opin Oncol,2008,20 ( 2 ) : 148 - 154. 被引量:1

二级参考文献13

共引文献8

同被引文献24

  • 1范理宏,蔡映云.神经内分泌分化与非小细胞肺癌[J].肿瘤,2006,26(6):579-581. 被引量:6
  • 2Howe MG,Chapman A,Kerr K,et al.Nenroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy[J].Histopathology,2005,46(2):195-201. 被引量:1
  • 3Walker GE.Antoniono RJ,Ross HJ,et al.Neuroendocrine-like differentiation of non-small cell lung carcinoma cells:regulation by cAMP and the interaction of mac25/IGFBP-rP1 and 25.1[J].Oncogene,2006,25(13):1943-1954. 被引量:1
  • 4Tavassolia F,Devilee P.World Health Organization classification of tumors Pathology and genetics tumors of the breast and female genital organs[M].Lyon:IARC Press,2003.32-34. 被引量:1
  • 5Slodkowska J,Zych J,Szturmowicz M,et al.Nenrocndocrine phenotypc of non-small cell lung carcinoma:immunohistological evaluation and biochemical study[J].Int J Biol Narkers,2005,20(4):217-226. 被引量:1
  • 6Sφrhaug S,Steinsbamn S,Haaverstad R,et al.Expression of neuroendocrine markers in non-small.cell lung cancer[J].APMIS,2007,115(2):152-163. 被引量:1
  • 7中国胃肠胰神经内分泌肿瘤病理专家组.中国胃肠胰神经内分泌肿瘤病理学诊断共识[J].中华病理学杂志,2011,. 被引量:11
  • 8Wagner L, Oliyarnyk O, Gartner W, et al. Cloning and expression of secretagogin, a novel neuroendocrine and pancreatic islet of Langer- hans-specific Ca2+-binding protein. J Biol Chem, 2000,275 : 24740- 24751. 被引量:1
  • 9Lai M, Lfi B, Xing X, et al. Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A. Virchows Arch,2006,449:402-409. 被引量:1
  • 10Orloff MJ. Carcinoid tumors of the rectum. Cancer, 1971,28 : 175-180. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部